A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE

RECRUITING

Research Site, New York

RECRUITING

Research Site, Buffalo

WITHDRAWN

Research Site, Rochester

RECRUITING

Research Site, Philadelphia

WITHDRAWN

Research Site, Fairfax

RECRUITING

Research Site, Charlottesville

RECRUITING

Research Site, Chapel Hill

RECRUITING

Research Site, Atlanta

RECRUITING

Research Site, Atlanta

COMPLETED

Research Site, Gainesville

RECRUITING

Research Site, Orlando

WITHDRAWN

Research Site, Miami

WITHDRAWN

Research Site, Miami

RECRUITING

Research Site, Columbus

RECRUITING

Research Site, Detroit

RECRUITING

Research Site, Milwaukee

RECRUITING

Research Site, Milwaukee

RECRUITING

Research Site, Chicago

RECRUITING

Research Site, St Louis

RECRUITING

Research Site, Houston

RECRUITING

Research Site, Aurora

RECRUITING

Research Site, Portland

RECRUITING

Research Site, Seattle

RECRUITING

Research Site, Boston

RECRUITING

Research Site, Trenton